Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea
· Delayed Price · Currency is KRW 51,100
-4,900 (-8.75%)
At close: Dec 5, 2025
43.14% (1Y)
| Market Cap | 2.59T |
| Revenue (ttm) | 154.05B |
| Net Income (ttm) | 2.31B |
| Shares Out | 50.78M |
| EPS (ttm) | 46.29 |
| PE Ratio | 1,123.15 |
| Forward PE | 358.90 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,313,698 |
| Average Volume | 1,128,830 |
| Open | 53,800 |
| Previous Close | 56,000 |
| Day's Range | 50,600 - 54,200 |
| 52-Week Range | 24,000 - 57,100 |
| Beta | 0.75 |
| RSI | 58.82 |
| Earnings Date | Nov 14, 2025 |